Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Ekso Bionics Holdings, Inc. (EKSO)

Compare
0.4189
+0.0069
+(1.67%)
As of 12:22:50 PM EDT. Market Open.
Loading Chart for EKSO
  • Previous Close 0.4120
  • Open 0.4240
  • Bid 0.2974 x 200
  • Ask 0.5448 x 200
  • Day's Range 0.4101 - 0.4289
  • 52 Week Range 0.3440 - 1.5300
  • Volume 39,624
  • Avg. Volume 235,198
  • Market Cap (intraday) 11.812M
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5600
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

www.eksobionics.com

61

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EKSO

View More

Performance Overview: EKSO

Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EKSO
31.33%
S&P 500 (^GSPC)
12.72%

1-Year Return

EKSO
68.27%
S&P 500 (^GSPC)
3.34%

3-Year Return

EKSO
83.56%
S&P 500 (^GSPC)
16.83%

5-Year Return

EKSO
88.00%
S&P 500 (^GSPC)
87.58%

Compare To: EKSO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EKSO

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    11.62M

  • Enterprise Value

    11.11M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.46

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    0.62

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -63.21%

  • Return on Assets (ttm)

    -23.53%

  • Return on Equity (ttm)

    -89.52%

  • Revenue (ttm)

    17.93M

  • Net Income Avi to Common (ttm)

    -11.33M

  • Diluted EPS (ttm)

    -0.5600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.49M

  • Total Debt/Equity (mrq)

    47.08%

  • Levered Free Cash Flow (ttm)

    -4.93M

Research Analysis: EKSO

View More

Company Insights: EKSO

Research Reports: EKSO

View More

People Also Watch